SAR Disease-Focused Panels: Cancer Imaging and Reporting Guidelines Online Course


Imaging is central to the diagnosis, treatment planning and monitoring of cancer patients. SAR Disease Focused Panels, comprised of abdominal radiologists with subspecialty expertise in each cancer type, have worked their clinical counterparts in surgery and oncology to develop standardized guidelines for image acquisition and exam reporting. This course will present these multidisciplinary consensus guidelines for imaging hepatocellular, pancreatic, ovarian, and prostatic cancers. The 2019 Bosniak classification for diagnosing cystic renal masses will also be presented. In-Training Members will receive a discounted price of $99 after login  


Target Audience:
The target audience for this activity is radiologists and radiologists in training with an interest in gastrointestinal imaging.

Goals and Objectives:
After completing the material in this article, the learner should be able to:
  1. Describe hepatocellular carcinoma and pancreatic adenocarcinoma CT and MRI after therapy.
  2. Describe ovarian, rectal, and anal cancer CT and MRI for staging and treatment planning.
  3. Discuss prostate cancer MRI for cancer detection.
  4. Discuss CT and MRI to classify cystic renal masses for likelihood of cancer.


Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners disclosures:

Planners
  • Courtney Moreno has nothing to disclose.
  • John Leyendecker has nothing to disclose.


Speakers/u>
  • Mukesh Harisinghani has nothing to disclose.
  • Tracy Jaffe has nothing to disclose.
  • Stuart Silverman has nothing to disclose.
  • Avinash Kambadakone has research grants from GE Healthcare, Philips, ECOG/ACRIN, and PanCAN. Dr. Kambadakone is a speaker for Philips.
  • Aradjana Venkatesan receives grant support from the Institutional Research Grant Program of the UT MD Anderson Cancer Center and the UT MD Anderson Cancer Center Support Grant (CCSG) Radiation Oncology and Cancer Imaging Program.
  • Susanna Lee has nothing to disclose.
  • Matthew Davenport is a consultant for NCI.
  • Alec Megibow receives a consulting fee from Bracco Diagnostics.
  • Andrei Purysko has a service agreement with Profound Medical and is the site PI for a clinical trial from Blue Earth Diagnostics, Ltd.
  • Mishal Mendiratta-Lala has nothing to disclose.


Member Price:
$195.00
NonMember Price:
$445.00

Accreditation Statement
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

Designation Statement
The ARRS designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credit(s)™ and 2 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Date of issuance: September 27, 2021
Date of expiration: September 26, 2024
Estimated time to complete the activity: 2 hour(s)